Search
AtriCure Inc
ATRCAdd to Watchlist
44.300USD
+0.810+1.86%
Close 08-14 16:00（ET）Quotes delayed by 15 min
2.25BMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of AtriCure Inc is 8.00, ranking 66 out of 201 in the Healthcare Equipment & Supplies industry. The average price target is 50.00, with a high of 64.00 and a low of 40.00.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
48.750
Target Price
+11.91%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
AtriCure Inc
ATRC
10
Stryker Corp
SYK
30
Medtronic PLC
MDT
30
Dexcom Inc
DXCM
30
Abbott Laboratories
ABT
29
Zimmer Biomet Holdings Inc
ZBH
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is AtriCure Inc's expected revenue for the next quarter?
AtriCure Inc's expected revenue is 151.22M.
What is AtriCure Inc's price target?
Analysts forecast that AtriCure Inc's price target is USD 50.00, with the highest forecast at USD 64.00 and the lowest forecast at USD 40.00.
What is the analyst rating for AtriCure Inc?
Based on the ratings of AtriCure Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.